Blood pressure drug shows promise against tough ovarian cancer

NCT ID NCT06815497

First seen Feb 01, 2026 · Last updated May 02, 2026 · Updated 10 times

Summary

This study tests whether adding the blood pressure drug telmisartan to standard chemotherapy can help people with a hard-to-treat type of ovarian cancer (platinum-resistant). About 33 adults with high-grade serous ovarian cancer that has stopped responding to platinum-based chemo will take telmisartan pills along with their usual chemo. The main goal is to see if this combination delays cancer growth compared to past results with chemo alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dartmouth Hitchcock

    RECRUITING

    Lebanon, New Hampshire, 03756, United States

    Contact

    Contact

  • Dartmouth-Hitchcock Manchester

    RECRUITING

    Manchester, New Hampshire, 03104, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.